Opportunity Information: Apply for CDC RFA PS10 1005
Apply for CDC RFA PS10 1005
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Tuberculosis Elimination and Laboratory Cooperative Agreements" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.116 Project Grants and Cooperative Agreements for Tuberculosis Control Programs.
- This funding opportunity was created on Jun 30, 2009 and posted on Jun 30, 2009.
- Applicants must submit their applications by Aug 28, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $92,300,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $10,450,782.00 in funding.
- The number of recipients for this funding is limited to 136 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this funding opportunity are listed below State and territorial governments (includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) or their Bona Fide Agents Political subdivisions of States (includes the cities of Chicago, Houston, Los Angeles, New York City, Philadelphia, San Diego, San Francisco, Detroit, and Baltimore) or their Bona Fide Agents, and in consultation with their state government)
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office, issued a discretionary Funding Opportunity Announcement (FOA) titled "Tuberculosis Elimination and Laboratory Cooperative Agreements" (Funding Opportunity Number: CDC-RFA-PS10-1005). This opportunity was designed to strengthen and support ongoing tuberculosis (TB) prevention and control work being carried out by state, local, and territorial TB programs, with the long-term goal of moving the United States closer to eliminating TB. The funding mechanism is a cooperative agreement, which typically means recipients will carry out program activities with substantial involvement from CDC in areas such as technical guidance, coordination, and performance oversight.
For fiscal year 2010, the CDC anticipated making 136 awards with an estimated total funding amount of about $92.3 million. Individual award amounts were expected to range from an award floor of $1,522,399 to an award ceiling of $10,450,782. There was no cost sharing or matching requirement stated for applicants, reducing the need for recipients to provide non-federal funds as a condition of receiving the award. The assistance listing tied to this program is CFDA 93.116, described as Project Grants and Cooperative Agreements for Tuberculosis Control Programs, placing it squarely within the federal public health funding framework for TB control and related laboratory capacity.
Eligibility was focused on governmental public health entities. Eligible applicants included state and territorial governments (including the District of Columbia and U.S. territories and freely associated states named in the announcement, such as Puerto Rico, Guam, American Samoa, the U.S. Virgin Islands, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) or their bona fide agents. Political subdivisions of states were also eligible, including specific large city health departments explicitly listed (Chicago, Houston, Los Angeles, New York City, Philadelphia, San Diego, San Francisco, Detroit, and Baltimore) or their bona fide agents, with the added requirement that these local jurisdictions apply in consultation with their state government. In other words, the program was aimed at public agencies with primary responsibility for TB control activities and the infrastructure to implement and coordinate surveillance, case management, contact investigations, and laboratory-related functions.
The timeline published with the announcement indicates it was posted on June 30, 2009, with an original and current closing date of August 28, 2009, and an archive date of September 27, 2009. The CDC indicated an estimated funding date of January 1, 2010. Applicants were directed to the full announcement on Grants.gov for complete program requirements and details, and a contact point was provided for access issues: the Technical Information Management Section (PGO TIMS) at 770-488-2700.
Frequently Asked Questions (FAQs)
1) What is the title of this funding opportunity?
The Funding Opportunity Announcement (FOA) is titled "Tuberculosis Elimination and Laboratory Cooperative Agreements".
2) What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is CDC-RFA-PS10-1005.
3) Which federal agency is offering this opportunity?
This opportunity was issued by the Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office.
4) What is the overall purpose of the program?
The purpose is to strengthen and support ongoing tuberculosis (TB) prevention and control work carried out by state, local, and territorial TB programs, with the long-term goal of moving the United States closer to eliminating TB.
5) What type of funding mechanism is used?
The mechanism is a cooperative agreement.
6) What does it mean that this is a cooperative agreement?
Based on the announcement description, a cooperative agreement generally means recipients conduct program activities with substantial CDC involvement in areas such as technical guidance, coordination, and performance oversight.
7) How many awards did CDC anticipate making for fiscal year 2010?
For fiscal year 2010, CDC anticipated making 136 awards.
8) What was the estimated total funding amount for fiscal year 2010?
The estimated total funding amount was about $92.3 million.
9) What was the expected range of individual award amounts?
Individual awards were expected to range from an award floor of $1,522,399 to an award ceiling of $10,450,782.
10) Is cost sharing or matching required?
No. The information provided states there was no cost sharing or matching requirement.
11) What is the CFDA (Assistance Listing) number associated with this program?
The Assistance Listing tied to this program is CFDA 93.116, described as Project Grants and Cooperative Agreements for Tuberculosis Control Programs.
12) Who is eligible to apply?
Eligibility was focused on governmental public health entities. Eligible applicants included:
- State and territorial governments (including the District of Columbia and U.S. territories and freely associated states named in the announcement) or their bona fide agents.
- Political subdivisions of states, including certain large city health departments explicitly listed, or their bona fide agents.
13) Which territories and freely associated states were specifically referenced as eligible?
The announcement referenced eligibility for the following (as listed): Puerto Rico, Guam, American Samoa, the U.S. Virgin Islands, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau, along with the District of Columbia.
14) Which large city health departments were explicitly listed as eligible political subdivisions?
The following large city health departments were explicitly listed: Chicago, Houston, Los Angeles, New York City, Philadelphia, San Diego, San Francisco, Detroit, and Baltimore (or their bona fide agents).
15) Do listed local jurisdictions have any special application requirement?
Yes. The information provided states that these local jurisdictions must apply in consultation with their state government.
16) What kinds of TB program activities was this opportunity intended to support?
The opportunity was aimed at public agencies with primary responsibility for TB control and the infrastructure to implement and coordinate activities such as surveillance, case management, contact investigations, and laboratory-related functions.
17) When was the FOA posted?
The FOA was posted on June 30, 2009.
18) What was the application closing date?
The original and current closing date listed was August 28, 2009.
19) When was the FOA archived?
The archive date listed was September 27, 2009.
20) What was the estimated funding date?
CDC indicated an estimated funding date of January 1, 2010.
21) Where were applicants directed to find the full announcement and complete requirements?
Applicants were directed to the full announcement on Grants.gov for complete program requirements and details.
22) Who should be contacted for access issues related to the announcement?
For access issues, the contact point provided was the Technical Information Management Section (PGO TIMS) at 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Brookwood Sago Mine Safety Grants
Previous opportunity: Conservation Innovation Grant
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 1005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 1005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Highly Innovative Tactics to Interrupt Transmission of HIV (HIT IT) (R01) Apply for RFA AI 09 037 Funding Number: RFA AI 09 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effectiveness Evaluation of Community Mitigation Activities During a Pandemic Apply for CDC RFA CI09 906 Funding Number: CDC RFA CI09 906 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Cooperative Agreement for the Physician Clinical Support System for the Treatment of Substance Use Disorders Apply for TI 10 001 Funding Number: TI 10 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $500,000 |
| CHILDRENS HEALTH INSURANCE PROGRAM REAUTHORIZATION ACT (CHIPRA) OUTREACH AND ENROLLMENT GRANTS CYCLE I Apply for HHS 2009 CMS CHIPRA 0008 Funding Number: HHS 2009 CMS CHIPRA 0008 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $1,000,000 |
| AHRQ Individual Awards for Postdoctoral Fellows (F32) Ruth L. Kirschstein National Research Service Awards (NRSA) Apply for PA 09 229 Funding Number: PA 09 229 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| AHRQ Developing Prospective Practice based Comparative Effectiveness Research Clinical Registries Orthopedic Devices, Drugs, and Procedures (P50) Apply for RFA HS 10 008 Funding Number: RFA HS 10 008 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| The Role of Apolipoprotein E, Lipoprotein Receptors and CNS Lipid Homeostasis in Brain Aging and Alzheimers Disease (R01) Apply for PA 09 217 Funding Number: PA 09 217 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Proteomics in Auditory Developmental and Disease Processes (R01) Apply for PA 09 228 Funding Number: PA 09 228 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Oral Mucosal Vaccination against HIV Infection (R01) Apply for RFA DE 10 001 Funding Number: RFA DE 10 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Public Health Emergency Response (PHER) Apply for CDC RFA TP09 902 H1N109 Funding Number: CDC RFA TP09 902 H1N109 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Support for Implementation and Expansion of HIV Prevention, Care and Treatment Services at National Teaching and Referral Hospitals (NT RHs) As Centers of Excellence in the Republic of Kenya Under The President s Emergency Fund for AIDS Relief (PEPF Apply for CDC RFA PS10 1004 Funding Number: CDC RFA PS10 1004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Strengthening Health Outcomes through the Private Sector (SHOPS) Apply for M OAA GH POP 09 0709 Funding Number: M OAA GH POP 09 0709 Agency: Agency for International Development Category: Health Funding Amount: $200,000,000 |
| Grants to States for Loan Repayment Apply for HRSA 09 228 Funding Number: HRSA 09 228 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NHLBI Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD Fellows (F30) Apply for PA 09 232 Funding Number: PA 09 232 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Partnerships with Product Development Public Private Partnerships (R01) Apply for RFA AI 09 034 Funding Number: RFA AI 09 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of New Technologies Needed for Studying the Human Microbiome (R01) Apply for RFA RM 09 008 Funding Number: RFA RM 09 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of New Technologies Needed for Studying the Human Microbiome (R21) Apply for RFA RM 09 009 Funding Number: RFA RM 09 009 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Epidemiological MCH/SPH Institute Apply for HRSA 09 265 Funding Number: HRSA 09 265 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Short Term Research Education Program to Increase Diversity in Health Related Research (R25) Apply for RFA HL 10 013 Funding Number: RFA HL 10 013 Agency: National Institutes of Health Category: Health Funding Amount: $106,250 |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (R01) Apply for RFA HG 09 011 Funding Number: RFA HG 09 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.